Role of lymphangiogenesis in epithelial ovarian cancer.
We investigated the significance of lymphatic count, vascular count and angiogenic growth factors using immunohistochemistry in 108 tumour specimens of epithelial ovarian cancer with antibodies to lymphatic vessel endothelial hyaluronan receptor (LYVE-1), platelet endothelial cell adhesion molecule...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2006
|
| _version_ | 1797064743527120896 |
|---|---|
| author | Sundar, S Zhang, H Brown, P Manek, S Han, C Kaur, K Charnock, M Jackson, D Ganesan, T |
| author_facet | Sundar, S Zhang, H Brown, P Manek, S Han, C Kaur, K Charnock, M Jackson, D Ganesan, T |
| author_sort | Sundar, S |
| collection | OXFORD |
| description | We investigated the significance of lymphatic count, vascular count and angiogenic growth factors using immunohistochemistry in 108 tumour specimens of epithelial ovarian cancer with antibodies to lymphatic vessel endothelial hyaluronan receptor (LYVE-1), platelet endothelial cell adhesion molecule CD31, vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) in epithelial ovarian cancer to understand the pathogenesis of metastasis in ovarian cancer. The effect of prognostic variables on progression-free and overall survival was assessed. On multivariate analysis, bulky residual disease after surgery was the best prognostic indicator (P<0.001) for progression-free and overall survival (P<0.001). Lymphatic count was statistically significant as a prognostic factor for progression-free (P=0.05) and overall survival (P=0.04). However, lymphatic count did not impact on survival curves. No correlation was found between lymphatic count and age, histological subtype, FIGO stage or residual disease. Vascular count, VEGF or TP expressions were not significant in either analysis. Lymphatic spread may be significant in aiding metastases in ovarian cancer but requires other biological factors to act in conjunction, as it does not have clearcut prognostic significance. Dissemination of ovarian cancer does not occur primarily through vascular or lymphatic routes but may occur through direct intraperitoneal spread of disease. |
| first_indexed | 2024-03-06T21:18:42Z |
| format | Journal article |
| id | oxford-uuid:40b72001-915b-4995-93e2-555fb0722288 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:18:42Z |
| publishDate | 2006 |
| record_format | dspace |
| spelling | oxford-uuid:40b72001-915b-4995-93e2-555fb07222882022-03-26T14:39:21ZRole of lymphangiogenesis in epithelial ovarian cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:40b72001-915b-4995-93e2-555fb0722288EnglishSymplectic Elements at Oxford2006Sundar, SZhang, HBrown, PManek, SHan, CKaur, KCharnock, MJackson, DGanesan, TWe investigated the significance of lymphatic count, vascular count and angiogenic growth factors using immunohistochemistry in 108 tumour specimens of epithelial ovarian cancer with antibodies to lymphatic vessel endothelial hyaluronan receptor (LYVE-1), platelet endothelial cell adhesion molecule CD31, vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) in epithelial ovarian cancer to understand the pathogenesis of metastasis in ovarian cancer. The effect of prognostic variables on progression-free and overall survival was assessed. On multivariate analysis, bulky residual disease after surgery was the best prognostic indicator (P<0.001) for progression-free and overall survival (P<0.001). Lymphatic count was statistically significant as a prognostic factor for progression-free (P=0.05) and overall survival (P=0.04). However, lymphatic count did not impact on survival curves. No correlation was found between lymphatic count and age, histological subtype, FIGO stage or residual disease. Vascular count, VEGF or TP expressions were not significant in either analysis. Lymphatic spread may be significant in aiding metastases in ovarian cancer but requires other biological factors to act in conjunction, as it does not have clearcut prognostic significance. Dissemination of ovarian cancer does not occur primarily through vascular or lymphatic routes but may occur through direct intraperitoneal spread of disease. |
| spellingShingle | Sundar, S Zhang, H Brown, P Manek, S Han, C Kaur, K Charnock, M Jackson, D Ganesan, T Role of lymphangiogenesis in epithelial ovarian cancer. |
| title | Role of lymphangiogenesis in epithelial ovarian cancer. |
| title_full | Role of lymphangiogenesis in epithelial ovarian cancer. |
| title_fullStr | Role of lymphangiogenesis in epithelial ovarian cancer. |
| title_full_unstemmed | Role of lymphangiogenesis in epithelial ovarian cancer. |
| title_short | Role of lymphangiogenesis in epithelial ovarian cancer. |
| title_sort | role of lymphangiogenesis in epithelial ovarian cancer |
| work_keys_str_mv | AT sundars roleoflymphangiogenesisinepithelialovariancancer AT zhangh roleoflymphangiogenesisinepithelialovariancancer AT brownp roleoflymphangiogenesisinepithelialovariancancer AT maneks roleoflymphangiogenesisinepithelialovariancancer AT hanc roleoflymphangiogenesisinepithelialovariancancer AT kaurk roleoflymphangiogenesisinepithelialovariancancer AT charnockm roleoflymphangiogenesisinepithelialovariancancer AT jacksond roleoflymphangiogenesisinepithelialovariancancer AT ganesant roleoflymphangiogenesisinepithelialovariancancer |